← Signal vs. Record
Unsupported Claim-check · last reviewed Jul 2026

'NAD+ reverses aging'

What was said
Boosting NAD+ — with NMN or NR supplements, or NAD+ IV drips — reverses aging and is a proven longevity breakthrough.
View the source statement →

Record basis: NAD+

A claim-check on the central NAD+ longevity claim. Verdict: unsupported.

What was said

Circulating across longevity influencers and clinic marketing: boosting NAD+ — via NMN, NR, or IV drips — reverses aging and is a proven longevity breakthrough S1.

What the record shows

  • Precursors reliably raise blood NAD+ levels, and there is a modest metabolic signal in specific groups (e.g., insulin sensitivity in prediabetic participants) S1.
  • But direct anti-aging or longevity benefit in humans is not established — most of the "reversal" evidence is from animal studies, and human trials are limited in scope and duration S1.
  • For IV NAD+, there are no rigorous randomized trials for anti-aging S2.

Reconciliation

The claim is unsupported: raising a biomarker (NAD+ levels) is not the same as reversing aging, and no robust human evidence shows the latter. "Boosts NAD+" is accurate; "reverses aging" outruns the data S1S2.

What would change this verdict

Adequately powered, long-term randomized human trials showing that raising NAD+ produces a durable clinical anti-aging or longevity outcome — none of which exist yet S1.

Sources

Every reference below is a primary source for the claim or the record.

  1. 01 The Safety and Antiaging Effects of NMN in Human Clinical Trials: an Update (review)
  2. 02 Frontiers in Aging — IV NAD+ versus NR: a retrospective tolerability pilot study